Please Wait
Applying Filters...
menu
    • menu
    CEP Q1 2026 Update: CEP 2.0, EDQM’s new guidelines strengthen ecosystem; Indian firms top list of CEPs issued

    DATA COMPILATION
    #PharmaFlow

    Pipeline Prospector March 2026 highlights: Lilly to acquire Centessa for US$ 7.8 bn; Merck buys Terns Pharma for US$ 6.7 bn

    Stock Recap
    #PipelineProspector

    Menu

    Irsogladine Maleate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PharmaCompass
    Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    31/03/2026 Chitose Hamari
    Japan
    		 Taejun Pharmaceutical Co., Ltd. Su17-1-ND Irsogladin maleate 2006-12-28 HAMARI PFST, Ltd. Japan 1007-81, Izumisawa, Chitose, Hokkaido, Japan
    31/03/2026 Daebong
    South Korea
    		 Daebong LS Co., Ltd. 618-2-ND Irsogladin maleate 2012-05-04 Daebong LS Co., Ltd. South Korea (405-820) 123, Neungheodae-ro 649beon-gil, Namdong-gu, Incheon (Gojan-dong), (Irsogladin Base Manufacturer: Heta Pharm&Chem Co., Ltd, No.8 Xiyuan Yi Road, Xihu Industrial Park Sandun, Hangzhou, Zheijiang, China 310030)
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.